Quant Healthcare Fund Direct Growth

Quant Healthcare Fund Direct Growth

Equity

Direct

Sector - Healthcare

NAV as on 11-12-2024

₹ 16.48

0.1%

1D

Inception Returns

42.8%

/yr

About Quant Healthcare Fund Direct Growth

Quant Healthcare Fund Direct Growth is an equity fund. This fund was started on 18 July, 2023. The fund is managed by Sanjeev Sharma, Ankit A. Pande. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Quant Healthcare Fund Direct Growth has ₹437 Cr worth of assets under management (AUM) as on Oct 2024 and is less than category average.
  2. The fund has an expense ratio 0.7.

Returns

Quant Healthcare Fund Direct Growth has given a CAGR return of 42.76% since inception. Over the last 1 year the fund has given a CAGR return of 40.10%.

Holdings

Quant Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Tech, Energy, Consumer Defensive, Basic Materials. Its top holdings are Aster DM Healthcare Ltd Ordinary Shares, RPG Life Sciences Ltd, HFCL Ltd, Pfizer Ltd, Reliance Industries Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 15%
For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefit
Dividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.

Investment objective of Quant Healthcare Fund Direct Growth

The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 1000.00. Quant Healthcare Fund Direct Growth has no lock in period.

Historical NAV & Returns

Annualised

zero opening, trading, fund transfer fee
1880 people have invested ₹ 2.7Cr in Quant Healthcare Fund Direct Growth in the last three months

Quant Healthcare Fund Direct Growth Overview

Expense ratio0.69%
Benchmark
S&P BSE Healthcare PR
AUM₹437 Cr
Inception Date18 July, 2023
Min Lumpsum/SIP₹5000/₹1000
Exit Load
1.0%
Lock InNo Lock-in
TurnOver
140.37%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

Trailing Returns

as on (11-Dec-24)

Period
Quant Healthcare Fund Direct Growth
Nifty 500
sector - healthcare
1M
-0.2%
3.4%
1.5%
3M
-7.7%
-0.7%
-0.3%
6M
10.8%
6.9%
19.6%
1Y
40.1%
24.4%
43.9%

Fund Distribution

as on (31-Oct-24)

  • Equity 99%

  • Debt & Cash 1%

Small cap
61.1%

Mid cap
17.9%

Large cap
15.7%

Sector Allocation

Oct'24

Sep'24

Aug'24

Health
79.2%
Energy
7.3%
Tech
6.9%
Consumer Defensive
6%
Basic Materials
0.6%
All changes are between Aug'24 and Oct'24
Oct'24
Sep'24
Aug'24
Fund Returns
-4.22%
0.14%
5.26%
Nifty 500
-6.52%
2.04%
0.97%
  • This fund’s returns stands at -4.22% whereas the fund’s underlying benchmark Nifty 500 returns stands at -6.52% as on Oct'24
  • This fund outperformed Nifty 500 by 2.30% in Oct'24
Parameters
Oct'24
Sep'24
Aug'24
AUM
₹ 453.8 Cr
₹ 453.8 Cr
₹ 431.5 Cr
  • AUM of the fund stands at 453.8 Cr as of Oct'24
  • AUM has remained same between Oct'24 and Sep'24
Top Stocks bought last month
RPG Life Sciences Ltd's allocation increased from 7.94% to 8.78%
RPG Life Sciences Ltd's allocation increased from 7.94% to 8.78%
Aster DM Healthcare Ltd Ordinary Shares's allocation increased from 6.45% to 7.17%
Aster DM Healthcare Ltd Ordinary Shares's allocation increased from 6.45% to 7.17%
Ipca Laboratories Ltd's allocation increased from 5.65% to 6.21%
Ipca Laboratories Ltd's allocation increased from 5.65% to 6.21%
Top Stocks sold last month
Reliance Industries Ltd's allocation decreased from 7.46 % to 6.98 %
Reliance Industries Ltd's allocation decreased from 7.46 % to 6.98 %
Aurobindo Pharma Ltd's allocation decreased from 6.99 % to 6.94 %
Aurobindo Pharma Ltd's allocation decreased from 6.99 % to 6.94 %
Pfizer Ltd's allocation decreased from 7.23 % to 6.68 %
Pfizer Ltd's allocation decreased from 7.23 % to 6.68 %
Large Cap allocation has gone down from 20.3% to 18.3%
Large Cap allocation has gone down from 20.3% to 18.3%
Small Cap allocation has gone up from 59.6% to 60.2%
Small Cap allocation has gone up from 59.6% to 60.2%
Mid Cap allocation has gone up from 18.8% to 19.4%
Mid Cap allocation has gone up from 18.8% to 19.4%
Cash allocation has gone up from 0.4% to 1.2%
Cash allocation has gone up from 0.4% to 1.2%

Top 3 Sectors in October were Health, Tech & Energy

Oct'24
Health
79%
Energy
7%
Tech
7%
Sep'24
Health
78%
Tech
8%
Energy
8%
  • Gainers

  • Losers

Top Growth Drivers
1M Return
Aster DM Healthcare Ltd
Aster DM Healthcare Ltd
12%
HFCL Ltd
HFCL Ltd
2.2%
Fund
Oct'24
Sep'24
Aug'24
No of Holdings
24
21
20
Top 5 Company Concentration
36.5%
37.4%
38.3%
Company having highest exposure
RPG Life Sciences Ltd (8.8%)
RPG Life Sciences Ltd (7.9%)
HFCL Ltd (8.3%)
No of Sectors
5
4
3
Top 5 Sectors Concentration
100%
100%
100%
Sector having highest exposure
Health (79.2%)
Health (77.9%)
Health (82.7%)
Loading...
We are taking more time than usual
Sanjeev Sharma
Sanjeev Sharma
Fund Manager of Quant Healthcare Fund Direct Growth, since 18 July 2023
Ankit A. Pande
Ankit A. Pande
Fund Manager of Quant Healthcare Fund Direct Growth, since 18 July 2023
Fund House
Quant Money Managers Limited
Total Schemes
Total AUM
₹1.01L Cr
as on 31-Oct-2024
Address
6th Floor, Sea Breeze Building,Appasaheb Marathe Marg, Prabhadevi
Phone
022-62955000
Website
help.investor@quant.in

Quant Healthcare Fund Direct Growth Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 42.76% since inception which is more than its category average return of 26.15%
Fund Allocations

Fund Allocations

This fund has an allocation of 98.97% in Equity, 0% in Debt and 1.03% in Cash related instruments
AUM size ₹437 Cr

AUM size ₹437 Cr

This fund has AUM of ₹437 Cr which is less than its category average of ₹ 1851 Cr
Expense Ratio 0.69%

Expense Ratio 0.69%

This fund has an expense ratio of 0.69% which is less than its category average expense ratio of 1.22%

Frequently Asked Questions for Quant Healthcare Fund Direct Growth

The current NAV of Quant Healthcare Fund Direct Growth is ₹16.48 as on 11-Dec-2024.
Existing (Absolute + CAGR) as on 11-Dec-2024.
Quant Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
-0.21%
-0.21%
6 Month Returns
10.84%
10.84%
1 Year Returns
40.1%
40.1%
3 Years Returns
0%
0%
5 Years Returns
0%
0%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
0.69% as on November 2024
₹437 Cr as on November 2024
Aster DM Healthcare Ltd Ordinary Shares(8.02%), RPG Life Sciences Ltd(7.72%), HFCL Ltd(7.02%), Pfizer Ltd(6.93%), Reliance Industries Ltd(6.91%) as on November 2024
Health(77.53%), Tech(7.27%), Energy(7.16%) as on November 2024
The alpha ratio for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Quant Healthcare Fund Direct Growth
5.54
-
-
As on November 2024
The alpha for Quant Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Quant Healthcare Fund Direct Growth
0.92
-
-
As on November 2024
The Beta for Quant Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Quant Healthcare Fund Direct Growth
1.89
-
-
As on November 2024
The sharpe ratio for Quant Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Quant Healthcare Fund Direct Growth
16.01
-
-
As on November 2024
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sanjeev Sharma, Ankit A. Pande are the fund managers of Quant Healthcare Fund Direct Growth
The Exit load of Quant Healthcare Fund Direct Growth is 1%